Patent details

EP3387019 Title: RELAXIN IMMUNOGLOBULIN FUSION PROTEINS AND METHODS OF USE

Basic Information

Publication number:
EP3387019
PCT Application Number:
US2016065779
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP168738995
PCT Publication Number:
WO2017100540
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
RELAXIN IMMUNOGLOBULIN FUSION PROTEINS AND METHODS OF USE
French Title of Invention:
PROTÉINES DE FUSION D'IMMUNOGLOBULINE DE RELAXINE ET PROCÉDÉS D'UTILISATION
German Title of Invention:
RELAXIN-IMMUNGLOBULIN-FUSIONSPROTEINE UND VERFAHREN ZUR VERWENDUNG
SPC Number:

Dates

Filing date:
09/12/2016
Grant date:
20/10/2021
EP Publication Date:
17/10/2018
PCT Publication Date:
15/06/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/10/2021
EP B1 Publication Date:
20/10/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
09/12/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/10/2021
 
 

Name:
The Scripps Research Institute
Address:
10550 North Torrey Pines Road, La Jolla, CA 92037, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
27/12/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
SCHULTZ, Peter G.
Address:
United States (US)

2

Name:
WANG, Ying
Address:
United States (US)

3

Name:
WANG, Feng
Address:
China (CN)

4

Name:
LIU, Yan
Address:
United States (US)

5

Name:
FU, Guangsen
Address:
United States (US)

Priority

Priority Number:
201562265344 P
Priority Date:
09/12/2015
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/46; A61K 39/395; A61P 35/00; C12N 15/09; C07K 16/10; C07K 14/64; A61P 11/00; A61P 13/12;

Publication

European Patent Bulletin

1

Issue number:
202142
Publication date:
20/10/2021
Description:
Grant (B1)

2

Issue number:
202147
Publication date:
24/11/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/12/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
28/11/2025
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
27/12/2021 Power Of Attorney 1
03/01/2022 Outgoing Correspondence 1